CDKN2A and neoplasm: There is evidence that p16 IHC shows strong diffuse cytoplasmic and nuclear staining in >70% of the tumor cells in SNSCC, though a lower rate than that for OPSCC (86) can be used as a surrogate marker (21, 34, 86).